Loading clinical trials...
Loading clinical trials...
The Comparative Efficacy and Safety of Sugammadex and Neostigmine in Reversing Neuromuscular Blockade After General Anesthesia: A Prospective Randomized Control Study
Conditions
Interventions
Neostigmine and Sugammadex
Locations
1
Taiwan
Yu-Hsun-Tsai
Taoyuan District, Taiwan
Start Date
September 6, 2021
Primary Completion Date
August 30, 2022
Completion Date
August 30, 2023
Last Updated
March 10, 2022
NCT05886218
NCT06962007
NCT06623370
NCT05708469
NCT05066035
NCT02025309
Lead Sponsor
Chang Gung Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions